You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Erdheim-Chester Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Erdheim-Chester Disease Trial in New York

Recruiting
  • Erdheim-Chester Disease
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 7, 2022

    Histiocytic Disorder Follow-up Study

    Recruiting
    • Histiocytosis
    • +5 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jun 13, 2023

      Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

      Active, not recruiting
      • Langerhans Cell Histiocytosis (LCH)
      • +2 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Aug 26, 2022

      Langerhans Cell Histiocytosis, Erdheim-Chester Disease, LCH Trial in Beijing (HLX208)

      Recruiting
      • Langerhans Cell Histiocytosis
      • +3 more
      • Beijing, China
        Peking Union Medical College Hospital
      Dec 30, 2021

      Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

      Recruiting
      • Langerhan's Cell Histiocytosis
      • +6 more
      • Phoenix, Arizona
      • +6 more
      Jan 12, 2023

      BRAF V600E Mutation Trial run by the NHGRI (Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide)

      Completed
      Has Results
      • BRAF V600E Mutation
      • Dabrafenib Mesylate
      • Trametinib Dimethyl Sulfoxide
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 6, 2021

      Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in

      Active, not recruiting
      • Rare Histiocytic Disorders (RHDs)
      • +7 more
      • Registry study
      • Los Angeles, California
      • +13 more
      Dec 13, 2022

      Erdheim-Chester Disease Trial in Houston (Dabrafenib Mesylate, Quality-of-Life Assessment, Questionnaire Administration)

      Withdrawn
      • Erdheim-Chester Disease
      • Dabrafenib Mesylate
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 16, 2021

      Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

      Recruiting
      • Solid Tumor
      • +11 more
      • Belfast, United Kingdom
      • +16 more
      Mar 2, 2023

      Biomarker for Farber Disease (BioFarber)

      Active, not recruiting
      • Farber's Lipogranulomatosis
      • +3 more
        • Cairo, Egypt
        • +2 more
        May 17, 2021

        Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

        Active, not recruiting
        • Advanced Malignant Neoplasm
        • +38 more
        • Bevacizumab
        • +5 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 18, 2022

        Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

        Active, not recruiting
        • Histiocytosis
        • Trail Making Test, Parts A & B
        • +10 more
        • Basking Ridge, New Jersey
        • +3 more
        Apr 1, 2022

        Erdheim Chester Disease

        Completed
        • Myelofibrosis
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jul 25, 2019

          Farber Disease Natural History Study

          Completed
          • Farber Disease
          • +6 more
            • Oakland, California
            • +14 more
            Jan 14, 2020

            Retroperitoneal Fibrosis, Tocilizumab Treatment Trial in Beijing (Tocilizumab treatment, Prednisone Monotherapy)

            Recruiting
            • Chronic Periaortitis
            • Tocilizumab Monotherapy
            • Tocilizumab monotherapy
            • Beijing, China
              Yunyun Fei
            Oct 22, 2022

            Histiocytosis Trial in Beijing (68Ga-FAPI)

            Not yet recruiting
            • Histiocytosis
            • 68Ga-FAPI
            • Beijing, China
              Department of Nuclear Medicine, Peking Union Medical College Hop
            Mar 25, 2023

            Dementia, Acute Medical Event, Hospitalization Trial in Baltimore, Philadelphia (FFC-AC-EIT)

            Recruiting
            • Dementia
            • +2 more
            • FFC-AC-EIT
            • Baltimore, Maryland
            • +11 more
            Jan 10, 2023

            Lower Extremity Fixation In Neuropathic Patients Study

            Terminated
            • Neuropathy
            • Charcot; Disease (Etiology)
            • SALVATION™ EXTERNAL FIXATION
            • Trinity, Florida
            • +2 more
            Jan 4, 2023

            Histiocytosis Trial in Warsaw (fluorodeoxyglucose (18F-FDG))

            Recruiting
            • Histiocytosis
            • fluorodeoxyglucose (18F-FDG)
            • Warsaw, Mazovian, Poland
              Mother and Child Institute
            Aug 2, 2022

            Histiocytosis Trial in Warsaw (Vemurafenib)

            Recruiting
            • Histiocytosis
            • Warsaw, Mazovian, Poland
              Mother and Child Institute
            Aug 2, 2022

            Schizophrenia, Bipolar I Disorder Trial in United States (OLZ/SAM, Olanzapine)

            Recruiting
            • Schizophrenia
            • Bipolar I Disorder
            • Dothan, Alabama
            • +4 more
            Aug 9, 2022

            Uptake and Biodistribution of 18F-fluorocholine in Histiocytic

            Completed
            • Erdheim-Chester Disease
            • +2 more
            • F-choline PET Scan
            • +2 more
            • New York, New York
              Memoral Sloan Kettering Cancer Center
            Aug 28, 2018

            Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)

            Recruiting
            • Kaposiform Hemangioendothelioma
            • Kasabach-Merritt Syndrome
            • Shanghai, Shanghai, China
              Children's Hospital of Fudan University
            Oct 21, 2022

            Pompe Disease Trial in Worldwide (ATB200, AT2221)

            Active, not recruiting
            • Pompe Disease
            • Phoenix, Arizona
            • +18 more
            Oct 19, 2021

            Persona Revision Knee System Outcomes

            Recruiting
            • Arthroplasty Complications
            • +3 more
            • Persona Revision Knee System
            • Fayetteville, Arkansas
            • +12 more
            May 9, 2022